等待開盤 10-31 09:30:00 美东时间
+0.005
+0.01%
 華盛通
華盛通Invivyd Inc. announced that the FDA has cleared the IND application for its REVOLUTION clinical program, advancing VYD2311, a monoclonal antibody candidate for COVID prevention. The DECLARATION Phase 3 trial will evaluate VYD2311's safety and efficacy vs. placebo for COVID prevention, with ~2,000 participants and options for single or monthly dosing. The LIBERTY trial will compare VYD2311's safety to mRNA vaccines and explore co-administration. B...
10-06 11:01
小程序:每日数字货币动态汇总 1. 美联储委员会警告稳定币可能对银行存款和信贷能力构成风险 近日披露的4月10日会议记录显示,美联储社区存款机构咨询委员会(C...
05-14 10:49
President Trump urges Fed to cut interest rates amid new tariffs, adding to economic uncertainty. 3 ETFs identified for potential gains.
03-21 04:30
Vanguard launches new Treasury-focused ETFs with low expense ratios to offer diversity and flexibility in fixed-income investing.
02-12 23:58